Monday, May 23, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

CRADA Opportunity: Developing Protein Nanoparticles for the Display of Viral Epitopes

by Global Biodefense Staff
March 13, 2019
Nanoscale CBRN Defense

Credit: Shutterstock

The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health seeks to partner with one or more biomedical companies in developing protein nanoparticles for the display of viral epitopes for vaccine use.

The Cooperative Research and Development Agreement (CRADA) would require the following capabilities:

  • Produce scaled- up purified recombinant protein nanoparticles
  • Measure antibody levels/titers elicited by nanoparticles
  • Measure neutralization capacity of antibodies to a panel of influenza viruses
  • Produce hydridomas or cDNA clones of neutralizing antibody genes elicited by nanoparticles
  • Produce quantities of antibodies sufficient for challenge and protection studies in animal models

CRADA partners will be expected to carry out additional immunogenicity studies in small animal mouse models with NIAID’s protein nanoparticles and if the data are promising, clinical studies may be discussed. It is especially desired that a prospective CRADA partner has expertise in performing and analyzing vaccination of animals with influenza immunogens/viruses and has the ability to perform challenge and protection studies in animals with a candidate influenza vaccine to expand on the initial studies performed by NIAID.

Additional details are available via FedBizOpps Solicitation Number: NIAID-TTIPO-2016-032.

Tags: InfluenzaNIAIDRFIVaccines

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs
Medical Countermeasures

New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs

April 10, 2022
Yersinia pestis
Funding News

NIH Awards $3M Grant to Albany Med for Plague Vaccine Development

April 8, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC